amino acid · for slow recovery
BCAAs
Switches on muscle rebuilding and limits the damage from a hard session.
Say that in clinical terms
Leucine activates mTOR signaling for muscle protein synthesis. BCAAs reduce DOMS by attenuating muscle damage markers.
How strong is the research?
Strong evidence
3 papers read, 3 supporting.
Who was studied: People deliberately drained of muscle fuel before an endurance test.
How much to take
daily
10–20 g
Most effective when taken immediately post-exercise.
Before you take it
- No NIH/IOM Tolerable Upper Intake Level (UL) has been established for BCAAs. The European BfR has derived a conservative supplemental guidance value of approximately 8.2 g/day total (all three BCAAs combined). Long-term safety data at doses above 20 g/day are limited.
- BCAAs compete with levodopa for the LAT1 large neutral amino acid transporter at the blood-brain barrier; elevated plasma BCAA levels can reduce CNS levodopa availability — a clinically documented interaction for Parkinson's disease patients on levodopa therapy. Neurologist consultation is required before supplementing BCAAs in this population.
- Leucine and isoleucine stimulate pancreatic insulin secretion; high BCAA doses may augment the glucose-lowering effect of insulin or oral hypoglycemic agents, raising theoretical hypoglycemia risk in individuals on those medications.
- Individuals with chronic kidney disease (CKD) face an increased renal nitrogen load from isolated amino acid supplements; those with advanced liver disease have impaired amino acid catabolism. Medical supervision is recommended in both populations before using isolated BCAA products.
- Insufficient safety data exist for use during pregnancy or lactation. Animal data indicate that high BCAA intake during early pregnancy may adversely affect fetal and placental growth. Use during pregnancy or breastfeeding should be physician-supervised.